Originele taal-2 | Engels |
---|---|
Pagina's (van-tot) | S88-S89 |
Tijdschrift | Leukemia Research |
Volume | 33 |
Nummer van het tijdschrift | SUPPL. 1 |
DOI's | |
Status | Gepubliceerd - mei 2009 |
Extern gepubliceerd | Ja |
Toegang tot document
Citeer dit
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Leukemia Research, Vol. 33, Nr. SUPPL. 1, 05.2009, blz. S88-S89.
Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review
TY - JOUR
T1 - P052 Acquired mutations in TET2 are common in myelodysplastic syndromes
AU - Langemeijer, S.
AU - Kuiper, R.
AU - Berends, M.
AU - Knops, R.
AU - Aslanyan, M.
AU - Massop, M.
AU - van Hoogen, P.
AU - van Kessel, A. Geurts
AU - Raymakers, R.
AU - Verburgh, E.
AU - Hagemeijer, A.
AU - Vandenberghe, P.
AU - de Witte, T.
AU - Van der Reijden, B.
AU - Jansen, J.
N1 - Funding Information: Laboratory, Biomedical Research Foundation, Academy of Athens, Athens, Greece; 2Laboratory of Cytogenetics, National Center for Scientific Research Demokritos, Greece; 3Department of Clinical Hematology, District General G.Gennimatas Hospital, Greece; 4Department of Pathophysiology, Medical School, National University of Athens, Greece; 5Department of Pathophysiology, Medical School, National University of Laboratory of Cytogenetics, National Center for Scientific Research Demokritos, Greece; 6Laboratory of Cytogenetics, National Center for Scientific Research Department of Pathophysiology, Medical School, National University of Athens, Greece; 7Department of Pathophysiology, Medical School, National University of Department of Hematology, Amalia Fleming General Hospital, Greece; 83rd Department of Internal Medicine, Sotiria Hospital, Medical School, University of Athens, Greece *E-mail: dahabreh@gmail.com
PY - 2009/5
Y1 - 2009/5
UR - http://www.scopus.com/inward/record.url?scp=65349155803&partnerID=8YFLogxK
U2 - 10.1016/S0145-2126(09)70132-8
DO - 10.1016/S0145-2126(09)70132-8
M3 - Article
AN - SCOPUS:65349155803
SN - 0145-2126
VL - 33
SP - S88-S89
JO - Leukemia Research
JF - Leukemia Research
IS - SUPPL. 1
ER -